Cost-effectiveness of vedolizumab compared with infliximab, adalimumab, and golimumab in patients with ulcerative colitis in the United Kingdom
Wilson, Michele R., Bergman, Annika, Chevrou-Severac, Helene, Selby, Ross, Smyth, Michael, Kerrigan, Matthew C.
Published in The European journal of health economics (01.03.2018)
Published in The European journal of health economics (01.03.2018)
Get full text
Journal Article
Cost-effectiveness of vedolizumab compared with conventional therapy for ulcerative colitis patients in the UK
Wilson, Michele R, Azzabi Zouraq, Ismail, Chevrou-Severac, Helene, Selby, Ross, Kerrigan, Matthew C
Published in ClinicoEconomics and outcomes research (01.01.2017)
Published in ClinicoEconomics and outcomes research (01.01.2017)
Get full text
Journal Article